Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Musculotendinous Inflammation: The Defining Pathology of Polymyalgia Rheumatica?

Owen CE, Liew DFL, Buchanan RRC.

J Rheumatol. 2019 Dec;46(12):1552-1555. doi: 10.3899/jrheum.190367. No abstract available.

PMID:
31787593
2.

Letter to the editor: Comments on 'A case of pembrolizumab-induced autoimmune haemolytic anaemia with polymyalgia rheumatica'.

Liew DFL, Owen CE, Buchanan RRC.

Eur J Cancer. 2019 Apr;111:59-60. doi: 10.1016/j.ejca.2018.11.034. Epub 2019 Feb 28. No abstract available.

PMID:
30826657
3.

Toward a Core Outcome Measurement Set for Polymyalgia Rheumatica: Report from the OMERACT 2018 Special Interest Group.

Owen CE, Yates M, Twohig H, Muller S, Neill LM, Harrison E, Shea B, Simon LS, Hill CL, Mackie SL.

J Rheumatol. 2019 Oct;46(10):1360-1364. doi: 10.3899/jrheum.181050. Epub 2019 Feb 1.

PMID:
30709960
4.

Prescribing for polymyalgia rheumatica.

Liew DF, Owen CE, Buchanan RR.

Aust Prescr. 2018 Feb;41(1):14-19. doi: 10.18773/austprescr.2018.001. Epub 2018 Feb 1. Review. No abstract available.

5.

The use of cyclosporine for Stevens-Johnson syndrome-toxic epidermal necrolysis spectrum at the University of Louisville: A case series and literature review.

Conner CD, McKenzie E, Owen CE, Callen JP.

Dermatol Online J. 2018 Jan 1;24(1). pii: 13030/qt6d56n4j8. Review.

6.

Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica.

Owen CE, Poon AMT, Lee ST, Yap LP, Zwar RB, McMenamin CM, Lam SKL, Liew DFL, Pathmaraj K, Kemp A, Scott AM, Buchanan RRC.

Rheumatology (Oxford). 2018 Feb 1;57(2):345-353. doi: 10.1093/rheumatology/kex411.

PMID:
29121248
7.

Fractionated Er:YAG laser versus fully ablative Er:YAG laser for scar revision: Results of a split scar, double blinded, prospective trial.

Tidwell WJ, Owen CE, Kulp-Shorten C, Maity A, McCall M, Brown TS.

Lasers Surg Med. 2016 Nov;48(9):837-843. doi: 10.1002/lsm.22562. Epub 2016 Jul 18.

PMID:
27426441
8.

Cutaneous manifestations of lung cancer.

Owen CE.

Semin Oncol. 2016 Jun;43(3):366-9. doi: 10.1053/j.seminoncol.2016.02.025. Epub 2016 Feb 23. Review.

PMID:
27178690
9.

Recent advances in polymyalgia rheumatica.

Owen CE, Buchanan RR, Hoi A.

Intern Med J. 2015 Nov;45(11):1102-8. doi: 10.1111/imj.12823. Review.

PMID:
26036315
10.

Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects.

Arm JP, Bottoli I, Skerjanec A, Floch D, Groenewegen A, Maahs S, Owen CE, Jones I, Lowe PJ.

Clin Exp Allergy. 2014 Nov;44(11):1371-85. doi: 10.1111/cea.12400.

11.

Treating acne with high-dose isotretinoin.

Owen CE.

JAMA. 2014 May;311(20):2121-2. doi: 10.1001/jama.2014.2323. No abstract available.

PMID:
24867015
12.

Solitary and multiple tumors of follicular infundibulum: a review of 168 cases with emphasis on staining patterns and clinical variants.

Alomari A, Subtil A, Owen CE, McNiff JM.

J Cutan Pathol. 2013 Jun;40(6):532-7. doi: 10.1111/cup.12137. Epub 2013 Mar 27.

PMID:
23531053
13.

Functional redundancy of class I phosphoinositide 3-kinase (PI3K) isoforms in signaling growth factor-mediated human neutrophil survival.

Juss JK, Hayhoe RP, Owen CE, Bruce I, Walmsley SR, Cowburn AS, Kulkarni S, Boyle KB, Stephens L, Hawkins PT, Chilvers ER, Condliffe AM.

PLoS One. 2012;7(9):e45933. doi: 10.1371/journal.pone.0045933. Epub 2012 Sep 24.

14.

Practice gaps. The need to examine the risks and benefits of intravenous immunoglobulin therapy in severe cutaneous adverse reactions.

Owen CE.

Arch Dermatol. 2012 Apr;148(4):545a-545. doi: 10.1001/archdermatol.2011.3156. No abstract available.

PMID:
22508889
15.

Cutaneous lymphoproliferative disorder complicating infectious mononucleosis in an immunosuppressed patient.

Owen CE, Callen JP, Bahrami S.

Pediatr Dermatol. 2011 Mar-Apr;28(2):149-55. doi: 10.1111/j.1525-1470.2010.01087.x.

PMID:
20497356
16.

Rare cutaneous manifestation of prostate cancer.

Van Meter JR, Owen CE, Bahrami S, Callen JP.

Arch Dermatol. 2010 Feb;146(2):206-8. doi: 10.1001/archdermatol.2009.381. No abstract available.

PMID:
20157042
17.

Sweet-like dermatosis in 2 patients with clinical features of dermatomyositis and underlying autoimmune disease.

Owen CE, Malone JC, Callen JP.

Arch Dermatol. 2008 Nov;144(11):1486-90. doi: 10.1001/archderm.144.11.1486.

PMID:
19015424
18.

African tick bite fever: a not-so-uncommon illness in international travelers.

Owen CE, Bahrami S, Malone JC, Callen JP, Kulp-Shorten CL.

Arch Dermatol. 2006 Oct;142(10):1312-4.

PMID:
17043186
19.

Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.

Owen CE.

Pharmacol Ther. 2007 Jan;113(1):121-33. Epub 2006 Sep 25. Review.

PMID:
17000005
20.
21.

Anti-immunoglobulin E therapy for asthma.

Owen CE.

Pulm Pharmacol Ther. 2002;15(5):417-24. Review.

PMID:
12406663
23.

The in vitro and in vivo pharmacology of antisense oligonucleotides targeted to murine Stat6.

Danahay H, Hill S, Natt F, Owen CE.

Inflamm Res. 2000 Dec;49(12):692-9.

PMID:
11211920
24.

Abrogation of lung inflammation in sensitized Stat6-deficient mice is dependent on the allergen inhalation procedure.

Trifilieff A, El-Hasim A, Corteling R, Owen CE.

Br J Pharmacol. 2000 Aug;130(7):1581-8.

25.

Dexamethasone does not significantly contribute to the response rate of docetaxel and estramustine in androgen independent prostate cancer.

Weitzman AL, Shelton G, Zuech N, Owen CE, Judge T, Benson M, Sawczuk I, Katz A, Olsson CA, Bagiella E, Pfaff C, Newhouse JH, Petrylak DP.

J Urol. 2000 Mar;163(3):834-7.

PMID:
10687988
26.

Primate homologues of rat TGN38: primary structure, expression and functional implications.

Ponnambalam S, Girotti M, Yaspo ML, Owen CE, Perry AC, Suganuma T, Nilsson T, Fried M, Banting G, Warren G.

J Cell Sci. 1996 Mar;109 ( Pt 3):675-85.

28.

Gene expression in the Streptomyces temperate phage phi C31.

Smith MC, Ingham CJ, Owen CE, Wood NT.

Gene. 1992 Jun 15;115(1-2):43-8.

PMID:
1612448

Supplemental Content

Support Center